Stay informed with the latest updates for the inheritable blood disorders community.

Industry
ICER Review of Emicizumab for People with Hemophilia A and Inhibitors
ICER Review of Emicizumab for People with Hemophilia A and Inhibitors
Industry
Genentech Provides Updates on Hemlibra Product Particles
Grifols Announces 2017 Factor Product Donations to WFH Humanitarian…
Industry
Genentech Announces Positive HEMLIBRA Trial Results
Statement from Genentech Regarding Hemlibra
Industry
New Inhibitor Screening Kit Unveiled at THSNA
New Inhibitor Screening Kit Unveiled at THSNA
Industry
NHF-McMasters Guidelines on ECRI
Aptevo Announces Patient-Reported Study Results Related to IXINITY® Use
Industry
Hemlibra Safety Update
Novo Nordisk Announces BLA Submission for Extended Half-Life FVIII Therapy…
Industry
Genentech Announces Positive HEMLIBRA Trial Results
REBINYN® Now Available for Hemophilia B Patients
Industry
New Inhibitor Screening Kit Unveiled at THSNA
Catalyst Begins Phase 2/3 Trial of Investigational Subcutaneous Therapy
Industry
Sangamo Announces First Patient Treated in Hemophilia B Gene Therapy Trial
BioMarin Reports Positive Gene Therapy Trial Data at ASH
Industry
Pfizer Initiates First Stage of Phase 3 Hemophilia B Gene Therapy Trial
Alnylam Announces FDA Lift of Hold on Fitusiran Trials
Industry
Shire and Rani Agree to Collaborate on Development of Orally-Administered Hemophilia A Therapy
Shire and Rani Agree to Collaborate on Development of…
Industry
Spark Reports Positive Clinical Trial Data on Hemophilia A and B Gene Therapies at ASH
Spark Reports Positive Clinical Trial Data on Hemophilia A and…
Industry
Genentech Announces Positive HEMLIBRA Trial Results
HEMLIBRA® Shows Prophylactic Efficacy in Hemophilia A Patients…
Industry
First Patient Enrolled in ITI Trial Using Eloctate
First Patient Enrolled in ITI Trial Using Eloctate
Industry
FDA Grants Orphan Drug Designation for Rofecoxib, Pain Medication for Hemophilia Arthropathy
FDA Grants Orphan Drug Designation for Rofecoxib, Pain…